• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.

作者信息

Wang Shu, Zhang Yingshi, Ren Tianshu, Wu Qiong, Lu Hongyuan, Qin Xiaochun, Liu Yuyan, Ding Huaiwei, Zhao Qingchun

机构信息

Department of Life Science and Biochemistry, Shenyang Pharmaceutical University, 110016, Shenyang, China.

Department of Pharmacy, General Hospital of Northern Theater Command, 110840, Shenyang, China.

出版信息

Cell Death Dis. 2025 Mar 27;16(1):216. doi: 10.1038/s41419-025-07539-7.

DOI:10.1038/s41419-025-07539-7
PMID:40148288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11950225/
Abstract
摘要

相似文献

1
Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.关注编辑声明：一种新型4-氨基喹唑啉衍生物DHW-208通过靶向PI3K/AKT/mTOR途径抑制人乳腺癌细胞的生长。
Cell Death Dis. 2025 Mar 27;16(1):216. doi: 10.1038/s41419-025-07539-7.
2
A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.一种新型的 4-氨基喹唑啉衍生物 DHW-208，通过靶向 PI3K/AKT/mTOR 通路抑制人乳腺癌细胞的生长。
Cell Death Dis. 2020 Jun 30;11(6):491. doi: 10.1038/s41419-020-2690-y.
3
DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis.新型磷脂酰肌醇3激酶（PI3K）抑制剂DHW-208通过促进凋亡和抑制血管生成发挥抗肝细胞癌活性。
Front Oncol. 2022 Jul 12;12:955729. doi: 10.3389/fonc.2022.955729. eCollection 2022.
4
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer.双靶点PI3K/mTOR抑制剂DHW-221通过靶向P-糖蛋白（P-gp/ABCB1）和Akt介导的FOXO3a核转位克服非小细胞肺癌的多药耐药性。
Front Oncol. 2022 May 13;12:873649. doi: 10.3389/fonc.2022.873649. eCollection 2022.
5
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway.ZDQ - 0620，一种新型磷脂酰肌醇3 - 激酶抑制剂，通过减弱PI3K/AKT/mTOR信号通路抑制结肠癌细胞增殖并抑制血管生成。
Front Oncol. 2022 Mar 2;12:848952. doi: 10.3389/fonc.2022.848952. eCollection 2022.
6
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.针对雌激素受体阳性乳腺癌中的 PI3K/AKT/mTOR 通路。
Cancer Treat Rev. 2014 Aug;40(7):862-71. doi: 10.1016/j.ctrv.2014.03.004. Epub 2014 Mar 26.
7
Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway.褪黑素通过靶向 PI3K/Akt/mTOR 通路对乳腺癌和卵巢癌的影响。
IUBMB Life. 2024 Dec;76(12):1035-1049. doi: 10.1002/iub.2900. Epub 2024 Aug 30.
8
Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling.乳腺癌分子靶向治疗的新方法：干扰 PI3K/AKT/mTOR 信号通路。
Curr Cancer Drug Targets. 2013 Feb;13(2):188-204. doi: 10.2174/1568009611313020008.
9
Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer.PI3K/AKT/mTOR抑制剂在晚期乳腺癌治疗中临床应用的专家共识
Cancer Innov. 2022 Jun 21;1(1):25-54. doi: 10.1002/cai2.10. eCollection 2022 Jun.
10
miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.微小RNA-218通过靶向PI3K/Akt/mTOR信号通路抑制结肠癌细胞的侵袭和迁移。
Int J Mol Med. 2015 May;35(5):1301-8. doi: 10.3892/ijmm.2015.2126. Epub 2015 Mar 6.

本文引用的文献

1
Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway.癌症相关成纤维细胞衍生的外泌体通过 miR-92/PD-L1 通路抑制乳腺癌中免疫细胞的功能。
Front Immunol. 2020 Oct 9;11:2026. doi: 10.3389/fimmu.2020.02026. eCollection 2020.
2
Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis.基于生物信息学和实验分析鉴定骨肉瘤转移相关基因生物标志物及潜在靶向药物
Onco Targets Ther. 2020 Aug 14;13:8095-8107. doi: 10.2147/OTT.S256617. eCollection 2020.